Wavefront aberrometers are diagnostic devices that measure aberrations of the eye from cornea to the retina. The device helps eye care practitioners to diagnose and cure eye ailments, and it is also used in laser eye surgery to ensure high accuracy. The light emitted by the device passes through the eye, measuring the light exiting the eye, enabling ophthalmologists to measure wavefront. An aberrometer helps doctors and physicians to screen patients with compromised vision and allows physicians to measure highly distorted eyes.

A wavefront aberrometer helps to produce a map of imperfections from the recorded data achieved from several spots on the surface of the cornea, thus providing information for performing customized laser eye surgery.

Wavefront Aberrometers Market: Dynamics

Increasing number of product launches, in order to improve the ability for correcting refractive errors is expected to drive the market growth. For instance, in August 2018, Essilor Instruments launched new Wave Analyzer Medica (WAM700+) wavefront aberrometer based on Shack-Hartmann wavefront technology, allowing simplified eye screening. The instrument features complete anterior chamber analysis and visual need assessment to assess conditions such as cataract, glaucoma, and others.

Increasing research and development activities favoring technological advancements and improving visual outcomes is expected to be a major factor fueling growth of the global wavefront aberrometers market over the forecast period. For instance, in 2013, WaveTec Vision, Inc. announced a hardware upgrade and commercial launch of VerifEye for the ORA system, intended to speed up the process and add continuous video and refractive readouts at the American Society of Cataract and Refractive Surgeons (ASCRS) meeting.

Wavefront Aberrometers Market: Regional Analysis

North America is expected to hold dominant position in the wavefront aberrometers market, owing to increasing number of ophthalmic cases and the contribution of technology to diagnose and treat many ocular diseases, including refractive errors. According to the Centers for Disease Control and Prevention (CDC), in 2015, around 11 million people in the U.S., aging 12 years and above, had vision impairment, which could be improved by correcting refractive errors. Moreover, around 3.3 million people in the U.S., aged 40 years and above, were estimated as legally blind or with low eye functioning.

Wavefront Aberrometers Market: Competitive Landscape

Key players operating in the wavefront aberrometers market include Abbott Medical Optics, Novartis AG, Carl Zeiss Meditec, Essilor instruments, Coburn Technologies, Inc., Luneau Technology USA, Inc., NIDEK CO., LTD, OPTIKON, SCHWIND eye-tech-solutions, and US Ophthalmic. Market players are focused on developing novel products to enable personalized treatment as per the patient. For instance, in 2015, the U.S. FDA approved Abbott's iDesign Advanced WaveScan Studio System, which creates an accurate and personalized LASIK treatment plan based on the unique blueprint of eyes.

Wavefront Aberrometers Market: Taxonomy

The global wavefront aberrometers market is segmented on the basis of product type, indication, end user, and region.

By Product Type-